• A Compounding Pharmacy YOU CAN TRUST

    Call UsText Us
  • Our People Make

    Call UsText Us
    Topical Medications

  • STERILE INJECTABLES Compounded Injectable Medications

    Our Official App Today!


Specialty Programs



Relief for Skin Irritations



Customized Pain Medications



Bioidentical Hormone Replacement Therapy



Healing and Soothing of Wounds and Sores



Cosmetic and Non-Cosmetic Effects



Reduction of Eye Sight Loss



Read more


“I developed an open wound on my right ankle. Everything that I was asked to do by my doctor didn’t work and the wound was actually getting worse. A compounding pharmacist suggested two compounded medicines to be applied daily. In two months, my open wound was closed and the pain was gone. The treatment worked as promised.”

M.L., Patient

“Within five days of using the topical solution, my chronic left knee pain subsided approximately 90%, my mental faculties were not impaired professionally, and I am able to sleep pain free. The topical solution developed by Dr. Lanier of Amex Pharmacy relieves[s] the chronic pain in my left knee. I find the topical solution much more effective than the Ibuprofen prescription.”

D.A., Patient

Accreditations and Associations



August 27, 2016
Melbourne, FL: From 2008 through 2014, average prices for the most widely used brand-name drugs jumped 128%, according to prescription-benefit manager Express Scripts Holding Co. In 2015, it is estimated that total US prescription-drug spending increased 13%. Reasons include increasing research costs, insufficient competition, and drug shortages. The AAD, American Association of Dermatology, has watched the price of RX drugs steadily increase over the years within its Specialty. According to the AAD, medications that for decades were affordable are now in many cases cost prohibitive, and increased cost for drugs has shown to lead to discontinuation and poor adherence to treatment. Noting this increase in med costs within the Dermatology Offices, AmEx Pharmacy began developing a line of affordable dermatological compound drugs for treating patients’ Actinic Keratosis or Sun Damage, Cutaneous Neoplasia, Psoriasis, Acne and Rosacea, Seborrheic Dermatitis, Atopic Dermatitis/Eczema, Pigmentation Disorders, Warts/HPV, and Hair Loss. Many of these common chronic skin disorders require a daily regimen to control symptoms and flare-ups. This often requires multiple creams, ointments, gels, lotions or cleansers to be applied throughout the day. This can become difficult and costly for patients, and can lead to non-compliance and treatment failure. AmEx Pharmacists have the expertise to combine multiple medications into a single medication, thus reducing cost, simplifying treatment regimens, and improving compliance. Medical science is often years ahead of manufactured products. Compounding gives prescribers the option to treat their patients with the most current therapies available. To learn more, call 800-644-9431, or text our pharmacists a question @ 321-872-0723.


August 24, 2016
A wise colleague recently sent us an article titled “Collaboration is the New Competition,” by Ben Hect, president and CEO of Living Cities. In the article, Hecht writes how even the best individual efforts can’t address complex problems without the help from others in today’s interconnected world. He states people are “putting aside self-interests and collaborating to build a new civic infrastructure to advance their shared objectives.” Hecht calls this trend collective impact. Collective impact perfectly illustrates the efforts taking place in Downtown Melbourne to address street-level chronic homelessness. Melbourne Florida In December of 2015, Melbourne Main Street hired a consultant to help understand how we as a community could better address street homelessness Downtown. The conversations were not easy, and the problem is not simple. Residents wanted a solution that addressed the needs of individuals in a dignified manner, and we also wanted a way to reduce the presence of homelessness in our Downtown and respond to the community. The key to improving the situation for everyone involved was collaboration, but you could not imagine the support that the town received and the partnerships built in the process. Last year I met Keith Donald, founder of Steadytown, and the individual who was leading the effort in partnership With the Daily Bread, Peace GAP Ministries, and the Brevard County Housing Authority leading the way, the city began to: Identify chronically homeless individuals in Melbourne. Get the identified homeless into permanent housing. Equip them with the supportive services needed to get entitled benefits. Get the mental and physical care they need to live a more purposeful life. Get the people back into the community, and the job market. The “Street to Home Movement” has now housed 40 chronically homeless individuals since December, none of which have returned to homelessness. Two key partners in these efforts have been the city of Melbourne and the Melbourne Police Department. The interest and pledge of support this Program received from Council, in addition to the police department’s willingness to use new means of addressing social disorders, has allowed the City of Melbourne to build a comprehensive ecosystem of support. Collaboration is the only way we can effectively make a change in the lives of some of the city’s most disadvantaged citizens while also paving the way for economic development in Downtown. For collaboration to be truly successful and meaningful, you have to allow for people to experiment and make mistakes. You have to foster a safe environment where people can confront difficult topics with different views, and you have to wholeheartedly focus on the work at-hand. To see social service organizations, city staff, and the MPD sitting at one table discussing best practices and lessons learned should fill our Residents with a sense of pride. We are successful because we all have each other to rely on. We are going to celebrate many success stories over the years in Melbourne and at Amex Pharmacy…and the best part is, we get to do it together.


August 17, 2016
Why do we have a National Health Calendar…two simple reasons: Awareness and Prevention. This month we thought we would help the awareness and spread word about new treatments regarding three of the health causes in August: Children’s Eye Health & Safety Month – Because we work with numerous retna and eye specialists on the sterile side of our business at Amex Pharmacy, and a majority of our employees have kids. August – Children’s Eye Health and Safety Month & Psoriasis Awareness Month Psoriasis Awareness Month – As a lot of great breakthroughs are taking place in the treatment of psoriasis with the Dermatologists Amex works with. (See Previous Amex Pharmacy Blog: New Wave Dermatology Southeast Regional Conference).  National Health Center Week – As we would like to point to our local Community Health Center right here in Melbourne, FL Sarno Family Healthcare, a member of the Brevard Health Alliance – http://www.bhachc.org/locations/sarno/. If you would like to learn more about the health causes in today’s blog, or to find out how you might be able to donate time or effort to a cause or event in your local community, please visit the below national Associations online: National Association of Community Health Centers 7200 Wisconsin Avenue, Suite 1100W Bethesda, MD 20814 (202) 296-3800 www.healthcenterweek.org Prevent Blindness  211 West Wacker Drive, Suite 1700 Chicago, IL 60606 (800) 331-2020 (312) 363-6001 (312) 363-6052 Fax info@preventblindness.org www.preventblindness.org National Psoriasis Foundation  6600 SW 92nd Avenue, Suite 300 Portland, OR 97223 (800) 723-9166 (503) 245-0626 Fax getinfo@psoriasis.org www.psoriasis.org If you have any questions regarding the content in our blog, please call our pharmacists at 800-644-9431, or feel free to text them at 321-872-0723. Our Pharmacists are available 24/7 for questions on this subject, or other Amex Pharmacy areas of expertise like Men’s ED Treatments, Dermatology Compounds, Topical Pain Relief, and more.  


August 15, 2016
For decades, the fabled Hazelden Foundation in St Paul MN has relied on group therapy, individual counseling and other nonmedical approaches to help tens of thousands of people recovering from drug and alcohol addiction. But several years ago Hazelden realized that too many of its opioid-addicted patients were dying of overdoses after dropping out of the traditional 12-step treatment programs. It was time to try a different approach. Breaking nearly 70 years of tradition, Hazelden in 2013 began offering patients in its 12-step program two addiction medications, buprenorphine and Vivitrol, to reduce their drug cravings. Three years later, the preliminary results are so promising they could prompt many medication skeptics to shift course. Hazelden offered the medications to 500 opioid addicts who participated in an intensive outpatient program between 2013 and 2015. Historically, about a quarter of patients quickly drop out of Hazelden’s 12-step program to go back to using drugs. But among the 500 people studied, that figure dropped to 5 percent. Approximately two-thirds of the patients in the program opted to try the drugs. “This is dramatic new evidence,” said Dr. Robert DuPont, a Maryland-based addiction specialist who served as the first director of the National Institute on Drug Abuse. “It’s revolutionary because it’s coming from Hazelden, which has always been a proponent of drug-free programs.” For years, national detox chains and residential rehab programs, some led by recovering addicts who conquered their own addictions without medication, have resisted using the drugs, despite research showing their effectiveness. More than two-thirds of U.S. clinics and treatment centers still do not offer them, and only about 1/5 of the people who would benefit from addiction medications are getting them. But Hazelden’s willingness to offer the medications and publicize the results could make a huge difference. “For the many mom-and-pop recovery programs out there who have modeled themselves after Hazelden, this is a game changer,” said David Gastfriend, a medical adviser to the Treatment Research Institute. “They’re not willing to take the scientists’ and the federal government’s word for it. But they can believe that medication works if they hear it from Hazelden.” Dr. Marvin Seppala, Hazelden’s medical director, emphasized the need for further study. Hazelden’s Butler Center For Research plans to follow 200 of Hazelden’s medication-assisted patients for a year to determine which medications worked best for which patients and how both medications compared to abstinence. The study, Seppala said, will examine the differences among the three groups — no medication, buprenorphine and Vivitrol — in length of time in treatment, relapse rates, readmission to treatment, length of time on medication, and overdose deaths, among other factors. “What we’re hoping to find is that certain personal traits determine which medication, or no medication, a patient may choose and which medications work best for certain patients,” Seppala said. “There are places that say everybody should be on medications and places that say nobody should,” Seppala said. “People are going to try these medications. If you had predictors for choosing which medications


August 10, 2016
According to a recent study that analyzed insurance records, health care claims for people with opioid dependence diagnoses rose more than 3,000 percent – from 217,000 to 7 million medical services – between 2007 and 2014. The study also suggested that 1) across all age groups, men were more likely than women to be diagnosed with dependency and 2) women were more likely than men to overdose. These findings also suggested that prevention and treatment should be more widely available. The findings illustrate that the opioid problem is “in the general mainstream,” says Robin Gelburd, president of Fair Health, a nonprofit that analyzes health care costs and conducted the study. The researchers used de-identified claims data from insurers representing 150 million patients who either have insurance through work or buy coverage on their own. They looked for diagnosis codes related to opioid dependency and abuse, adverse effects of heroin use or problems caused by the misuse or abuse of other types of opiates, including prescription drugs. The study found that health care costs related to opioid dependence increased most sharply since 2011, a period marked by increased attention to the problem and a growing pressure on physicians to reduce the number of opioid prescriptions. Younger patients ages 19 to 35 were most likely to be diagnosed as opioid dependent. Those younger patients were also more likely than older ones to overdose on heroin. The reverse was true for overdoses related to other types of opioids, which were more common in people in their mid-40s to mid-50s. Still, basing an analysis solely on insurance claims data, while common, may not paint a complete picture. The accuracy of billing codes may be poor, for example. In this case, increased attention to the opioid problem may have also resulted in an increased use of related codes. Some research studies also pair claims data with medical record information, which includes doctors’ notes. This study did not. Other findings include: Across all age groups, men were more likely than women to be diagnosed with dependency. That gap narrowed among patients in their 40s and 50s, with women representing 45 percent of those diagnosed. Women were more likely than men to overdose. The ratio of opioid dependence to other substance abuse problems varied by state. Rhode Island had the highest ratio of opioid problems, while Maine and Montana had the lowest. Data from IMS Health, which tracks prescription drug sales, shows the number of prescriptions for opioid-based drugs have ticked down, falling 11.8 percent from 2012 to 2015. That decline, however, followed a huge increase: The number of opioid prescriptions more than doubled between 2000 and 2012, when more than 282 million prescriptions were written. The data from Fair Health truly shows the scope of the problem; this is not limited to a problem of the poor and unemployed, this is a problem that is cutting right across society. In mid-July, President Obama signed the Comprehensive Addition and Recovery Act of 2016, which aims to make